Notice ID: de4ca599c5664b31b4e0f9360378a98cAward NoticeAwarded
6505--Trastuzumab Biosimilars (VA-20-00060347)
Awarded on September 14, 2020. Full description on SAM.gov.
Awarded tounder 36E79720D0070 (source: SAM.gov award notice)• $22.6M
Overview
- Posted
- September 14, 2020
- Notice type
- Award Notice
Notice details
- Last updated
- Apr 29, 2026
- Award date
- Sep 14, 2020
- Award amount (SAM.gov award notice)
- $22.6M
Identifiers
- Solicitation number
- 36E79720R0057
- Notice ID
- de4ca599c5664b31b4e0f9360378a98c
- Award number (PIID)
- 36E79720D0070
Description
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79720R0057 for an unrestrictive procurement for Trastuzumab or Biosimilar, 150MG Vial, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79720R0057 will be electronically issued in commercial item format in accordance with FAR Part 12 early to mid-July. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: https://beta.sam.gov. No paper copies of the solicitation will be available, and no telephone request for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Youlanda Duggar. Questions can be e-mailed to: Youlanda.Duggar@va.gov. The estimated annual requirements are as follows: Item Description Size (Vial) Estimated Annual Requirements 1 Trastuzumab or Biosimilar, 150MG 1 11,323
Award Overview
Award Number
36E79720D0070
Award Amount (SAM.gov award notice)
$22.6M
Award Date
Sep 14, 2020
Awardee
Awardee UEI
QTT6LXC3YKE9
Original Solicitation
Notice ID: de4ca599c5664b31b4e0f9360378a98c
Posted Date: Sep 14, 2020
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Oct 19, 2026
- —Signed Sep 10, 2026
- —Signed Sep 1, 2026
- —Signed Aug 21, 2026
- —Signed Jul 21, 2026
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36E79720R0057- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- Pre-SolicitationJun 19, 2020
6505--Trastuzumab Biosimilars (VA-20-00060347)
- SolicitationJul 10, 2020
6505--Trastuzumab Biosimilars (VA-20-00060347)
- AwardedCurrentSep 14, 2020
6505--Trastuzumab Biosimilars (VA-20-00060347)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36E79720R0057
Archive Date
Dec 22, 2020
Office Address
HINES, IL, 60141